Archive for the ‘Cardiovascular’ Category
Monday, February 18th, 2008
Reacting to the release of the ENHANCE trial results that showed Vytorin, a combination of the statin simvastatin (Zocor) and ezetimibe (Zetia), provides no benefit over simvastatin alone in preventing the progress of arterial plaque buildup, physicians indicate they will shift Vytorin heavily to third-line, rather than first- or second- ...
Posted in Cardiovascular | No Comments »
Monday, February 18th, 2008
The Sorin Group (MIL:SRN), the largest European cardiovascular company and world leader in medical technologies for cardiac surgery, is supporting a clinical trial of the Sorin MEMO 3DTM Annuloplasty Ring for mitral valve repair. The purpose of the study is to evaluate the effectiveness and clinical outcomes of MEMO 3D™ ...
Posted in Cardiovascular | No Comments »
Monday, February 18th, 2008
Despite an ageing population, outcomes for coronary artery bypass graft (CABG) surgery patients in Victoria remained steady between 2001 and 2006, and 30-day mortality rates are still low, according to a study published in the latest Medical Journal of Australia.
Dr Diem Dinh - Research Fellow at the Department of Epidemiology ...
Posted in Cardiovascular | No Comments »
Saturday, February 9th, 2008
George W. Vetrovec, M.D., chair of cardiology at the Virginia Commonwealth University Medical Center, known nationally for his study and treatment of coronary artery disease, says a new technique for treating blocked coronary arteries shows promise, but is best performed by experienced physicians.
The editorial review, Improving Reperfusion in Patients with ...
Posted in Cardiovascular | No Comments »
Friday, February 8th, 2008
When used during on-pump cardiac surgery, the blood-conserving drug aprotinin appears to be safe. However, when used in combination with angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery, it has been associated with a significant risk of renal dysfunction in the postoperative phase. This is the conclusion of authors Mouton, ...
Posted in Cardiovascular | No Comments »
Thursday, February 7th, 2008
Part of a large North American clinical trial comparing aggressive with less aggressive blood sugar treatment of diabetes and cardiovascular disease in adults with type 2 diabetes has stopped 18 months early because the more aggressive treatment increased risk of death. The less aggressive treatment arm of the study has ...
Posted in Cardiovascular, Diabetes | No Comments »
Thursday, February 7th, 2008
St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval of two integrated components: the Cool Point(TM) Irrigation Pump and the IBI-1500T11 Cardiac Ablation Generator. Designed to enhance physicians' ability to perform successful cardiac ablations, the integrated components were developed for use together with the St. Jude Medical family of ...
Posted in Cardiovascular | No Comments »
Monday, December 3rd, 2007
New results announced at TCT continue to demonstrate that Boston Scientific's drug-eluting stents (DES) are just as safe as and more effectiafeve than bare-metal stents (BMS) when used according with their Directions for Use.
As Safe As A BMS
- In more than 61,000 patients in seven real world registries, five (ASAN,1 ...
Posted in Cardiovascular | No Comments »
Wednesday, November 7th, 2007
Acusphere, Inc. (NASDAQ: ACUS) announced that data from its Phase 3 RAMP-1 (real time assessment of myocardial perfusion) and RAMP-2 clinical trials of Imagify™ (Perflubutane Polymer Microspheres) for Injectable Suspension were presented at the annual American Heart Association meeting in Orlando, Florida. The results from these international multi-center trials indicate ...
Posted in Cardiovascular | No Comments »
